Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Change in Cash (2019 - 2025)

Historic Change in Cash for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to -$71.1 million.

  • Cresco Labs' Change in Cash fell 27499.32% to -$71.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.5 million, marking a year-over-year decrease of 18606.85%. This contributed to the annual value of $35.7 million for FY2024, which is 37508.85% up from last year.
  • Cresco Labs' Change in Cash amounted to -$71.1 million in Q3 2025, which was down 27499.32% from -$15.6 million recorded in Q4 2024.
  • In the past 5 years, Cresco Labs' Change in Cash registered a high of $118.2 million during Q1 2021, and its lowest value of -$123.7 million during Q2 2021.
  • Its 5-year average for Change in Cash is -$10.0 million, with a median of -$13.2 million in 2022.
  • As far as peak fluctuations go, Cresco Labs' Change in Cash skyrocketed by 59429.63% in 2021, and later tumbled by 27499.32% in 2025.
  • Over the past 5 years, Cresco Labs' Change in Cash (Quarter) stood at $28.7 million in 2021, then crashed by 137.67% to -$10.8 million in 2022, then skyrocketed by 58.41% to -$4.5 million in 2023, then plummeted by 245.91% to -$15.6 million in 2024, then tumbled by 356.89% to -$71.1 million in 2025.
  • Its Change in Cash stands at -$71.1 million for Q3 2025, versus -$15.6 million for Q4 2024 and $40.6 million for Q3 2024.